V020-0545 Screening compound: 2-[1-(4-methoxyphenyl)-N-[(oxolan-2-yl)methyl]formamido]-N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

V020-0545 Screening compound: 2-[1-(4-methoxyphenyl)-N-[(oxolan-2-yl)methyl]formamido]-N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide
V020-0545 Screening compound: 2-[1-(4-methoxyphenyl)-N-[(oxolan-2-yl)methyl]formamido]-N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-0545
2-[1-(4-methoxyphenyl)-N-[(oxolan-2-yl)methyl]formamido]-N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-0545

Molecular Formula

C31H32N4O4 (C31 H32 N4 O4)

Compound Name

2-[1-(4-methoxyphenyl)-N-[(oxolan-2-yl)methyl]formamido]-N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

IUPAC name

2-[1-(4-methoxyphenyl)-N-[(oxolan-2-yl)methyl]formamido]-N-[1-(3-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

SMILES

Cc1cccc(-n2c(NC(CN(CC3OCCC3)C(c(cc3)ccc3OC)=O)=O)nc(-c3ccccc3)c2)c1

InChI

InChI=1S/C31H32N4O4/c1-22-8-6-11-25(18-22)35-20-28(23-9-4-3-5-10-23)32-31(35)33-29(36)21-34(19-27-12-7-17-39-27)30(37)24-13-15-26(38-2)16-14-24/h3-6,8-11,13-16,18,20,27H,7,12,17,19,21H2,1-2H3,(H,32,33,36)/t27-/m1/s1

InChI Key

QHVYXGMONCAFBX-HHHXNRCGSA-N

MDL Number (MFCD)

MFCD19821872

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

524.62

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.994

Distribution Coefficient, logD

4.994

Water Solubility, LogSw

-4.57

Polar Surface Area

68.591

Acid Dissociation Constant (pKa)

13.82

Base Dissociation Constant (pKb)

3.46

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

25.80

V020-0545 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V020-0545 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-0545?
Check Price and Availability of V020-0545, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-0545 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-0545
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-0545
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-0545 available by request